FRA: D8Y0

Swiss pharmaceutical giant Novartis (NYSE: NVS) has announced October 4 of this year as the tentative date for the complete spin-off of its generics and biosimilars subsidiary, Sandoz (FRA: D8Y0). Prior to this, a crucial shareholder meeting is scheduled for September 15, where a vote will be held on the…